Molecular imaging with spectral CT nanoprobes

Dipanjan Pan, Anne H. Schmieder, Angana SenPan, Xiaoxia Yang, Samuel A. Wickline, Ewald Roessl, Roland Proksa, Carsten O. Schirra, Gregory M. Lanza

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

X-ray contrast agents have heretofore been dominated by iodinated molecules imaged with computed tomography (CT) using traditional energy integrating detectors. Hardware and software developments in CT now present the option for dual-energy detection systems, which still retain the integrator detector approach. However, a new era of detectors called photon-counting detectors used for spectral CT has recently overcome many of the technical imaging barriers precluding clinical translation while offering a trade-off between higher image resolution or better signal to noise as well as lower radiation exposure. While these attributes are highly desirable, the unmet potential for Spectral CT is molecular imaging due to the energy discriminating properties of these systems. To date, contrast imaging is based on X-ray attenuation as seen routinely when high calcium content, such as in bone, appears white on the image. With spectral CT, individual metals, particularly gold, tantalum, bismuth, and ytterbium have emerged as the basis for new contrast media, which are referred to as K-edge contrast agents. These new agents could be used to localize and quantify important biomarkers to extend CT tissue characterization into the realm of molecular imaging. While many of the prototype attempts at such agents will likely not be translational to patients, an array of concepts, reviewed herein, could lead to clinical products in the not too distant future.

Original languageEnglish (US)
Title of host publicationDesign and Applications of Nanoparticles in Biomedical Imaging
PublisherSpringer International Publishing
Pages385-402
Number of pages18
ISBN (Electronic)9783319421698
ISBN (Print)9783319421674
DOIs
StatePublished - Jan 1 2016

Fingerprint

Nanoprobes
Molecular imaging
Molecular Imaging
Tomography
Contrast Media
Detectors
Ytterbium
X-Rays
Tantalum
Contrast media
Imaging techniques
X rays
Bismuth
Biomarkers
Image resolution
Photons
Gold
Computer hardware
Noise
Calcium

Keywords

  • Computed tomography
  • K-edge
  • Molecular imaging
  • Nanoparticle

ASJC Scopus subject areas

  • Medicine(all)
  • Health Professions(all)
  • Engineering(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Pan, D., Schmieder, A. H., SenPan, A., Yang, X., Wickline, S. A., Roessl, E., ... Lanza, G. M. (2016). Molecular imaging with spectral CT nanoprobes. In Design and Applications of Nanoparticles in Biomedical Imaging (pp. 385-402). Springer International Publishing. https://doi.org/10.1007/978-3-319-42169-8_18

Molecular imaging with spectral CT nanoprobes. / Pan, Dipanjan; Schmieder, Anne H.; SenPan, Angana; Yang, Xiaoxia; Wickline, Samuel A.; Roessl, Ewald; Proksa, Roland; Schirra, Carsten O.; Lanza, Gregory M.

Design and Applications of Nanoparticles in Biomedical Imaging. Springer International Publishing, 2016. p. 385-402.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pan, D, Schmieder, AH, SenPan, A, Yang, X, Wickline, SA, Roessl, E, Proksa, R, Schirra, CO & Lanza, GM 2016, Molecular imaging with spectral CT nanoprobes. in Design and Applications of Nanoparticles in Biomedical Imaging. Springer International Publishing, pp. 385-402. https://doi.org/10.1007/978-3-319-42169-8_18
Pan D, Schmieder AH, SenPan A, Yang X, Wickline SA, Roessl E et al. Molecular imaging with spectral CT nanoprobes. In Design and Applications of Nanoparticles in Biomedical Imaging. Springer International Publishing. 2016. p. 385-402 https://doi.org/10.1007/978-3-319-42169-8_18
Pan, Dipanjan ; Schmieder, Anne H. ; SenPan, Angana ; Yang, Xiaoxia ; Wickline, Samuel A. ; Roessl, Ewald ; Proksa, Roland ; Schirra, Carsten O. ; Lanza, Gregory M. / Molecular imaging with spectral CT nanoprobes. Design and Applications of Nanoparticles in Biomedical Imaging. Springer International Publishing, 2016. pp. 385-402
@inbook{f4e86ccaeb16417ea4d25c6f2d6bc39e,
title = "Molecular imaging with spectral CT nanoprobes",
abstract = "X-ray contrast agents have heretofore been dominated by iodinated molecules imaged with computed tomography (CT) using traditional energy integrating detectors. Hardware and software developments in CT now present the option for dual-energy detection systems, which still retain the integrator detector approach. However, a new era of detectors called photon-counting detectors used for spectral CT has recently overcome many of the technical imaging barriers precluding clinical translation while offering a trade-off between higher image resolution or better signal to noise as well as lower radiation exposure. While these attributes are highly desirable, the unmet potential for Spectral CT is molecular imaging due to the energy discriminating properties of these systems. To date, contrast imaging is based on X-ray attenuation as seen routinely when high calcium content, such as in bone, appears white on the image. With spectral CT, individual metals, particularly gold, tantalum, bismuth, and ytterbium have emerged as the basis for new contrast media, which are referred to as K-edge contrast agents. These new agents could be used to localize and quantify important biomarkers to extend CT tissue characterization into the realm of molecular imaging. While many of the prototype attempts at such agents will likely not be translational to patients, an array of concepts, reviewed herein, could lead to clinical products in the not too distant future.",
keywords = "Computed tomography, K-edge, Molecular imaging, Nanoparticle",
author = "Dipanjan Pan and Schmieder, {Anne H.} and Angana SenPan and Xiaoxia Yang and Wickline, {Samuel A.} and Ewald Roessl and Roland Proksa and Schirra, {Carsten O.} and Lanza, {Gregory M.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-42169-8_18",
language = "English (US)",
isbn = "9783319421674",
pages = "385--402",
booktitle = "Design and Applications of Nanoparticles in Biomedical Imaging",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Molecular imaging with spectral CT nanoprobes

AU - Pan, Dipanjan

AU - Schmieder, Anne H.

AU - SenPan, Angana

AU - Yang, Xiaoxia

AU - Wickline, Samuel A.

AU - Roessl, Ewald

AU - Proksa, Roland

AU - Schirra, Carsten O.

AU - Lanza, Gregory M.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - X-ray contrast agents have heretofore been dominated by iodinated molecules imaged with computed tomography (CT) using traditional energy integrating detectors. Hardware and software developments in CT now present the option for dual-energy detection systems, which still retain the integrator detector approach. However, a new era of detectors called photon-counting detectors used for spectral CT has recently overcome many of the technical imaging barriers precluding clinical translation while offering a trade-off between higher image resolution or better signal to noise as well as lower radiation exposure. While these attributes are highly desirable, the unmet potential for Spectral CT is molecular imaging due to the energy discriminating properties of these systems. To date, contrast imaging is based on X-ray attenuation as seen routinely when high calcium content, such as in bone, appears white on the image. With spectral CT, individual metals, particularly gold, tantalum, bismuth, and ytterbium have emerged as the basis for new contrast media, which are referred to as K-edge contrast agents. These new agents could be used to localize and quantify important biomarkers to extend CT tissue characterization into the realm of molecular imaging. While many of the prototype attempts at such agents will likely not be translational to patients, an array of concepts, reviewed herein, could lead to clinical products in the not too distant future.

AB - X-ray contrast agents have heretofore been dominated by iodinated molecules imaged with computed tomography (CT) using traditional energy integrating detectors. Hardware and software developments in CT now present the option for dual-energy detection systems, which still retain the integrator detector approach. However, a new era of detectors called photon-counting detectors used for spectral CT has recently overcome many of the technical imaging barriers precluding clinical translation while offering a trade-off between higher image resolution or better signal to noise as well as lower radiation exposure. While these attributes are highly desirable, the unmet potential for Spectral CT is molecular imaging due to the energy discriminating properties of these systems. To date, contrast imaging is based on X-ray attenuation as seen routinely when high calcium content, such as in bone, appears white on the image. With spectral CT, individual metals, particularly gold, tantalum, bismuth, and ytterbium have emerged as the basis for new contrast media, which are referred to as K-edge contrast agents. These new agents could be used to localize and quantify important biomarkers to extend CT tissue characterization into the realm of molecular imaging. While many of the prototype attempts at such agents will likely not be translational to patients, an array of concepts, reviewed herein, could lead to clinical products in the not too distant future.

KW - Computed tomography

KW - K-edge

KW - Molecular imaging

KW - Nanoparticle

UR - http://www.scopus.com/inward/record.url?scp=85009687760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009687760&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-42169-8_18

DO - 10.1007/978-3-319-42169-8_18

M3 - Chapter

AN - SCOPUS:85009687760

SN - 9783319421674

SP - 385

EP - 402

BT - Design and Applications of Nanoparticles in Biomedical Imaging

PB - Springer International Publishing

ER -